
Thursday, July 07, 2022 6:23:20 AM
Press Release | 07/06/2022
Will Become a Shareholder and Partner of FansFrenzy Corporation (OTC:FFZY) in Future Projects.
Las Vegas, NV, July 6, 2022. FansFrenzy Corporation (the "Company") (OTC: FFZY) is pleased to announce Anishinaabe Protector Foundations investment of six million two hundred and fifty US dollars ($6,250,000) will consist of the following:
Two million dollars ($2,000,000) will result in the issuance of eight million (8,000,000) common shares, and eight million (8,000,000) warrants convertible into common shares at the price of sixty cents ($0.60) per share. The warrants will have a conversion rate of one warrant to one common share.
FansFrenzy will create and issue a special class of non-voting Convertible Preferred Series B shares for the balance of four million two hundred and fifty thousand dollars ($4,250,000). Anishinaabe Protector Foundation therefore becomes a shareholder and partner in our future projects.
About Anishinaabe Protector Foundation
Anishinaabe Protector Foundation is a private Foundation located in NY State. Mission and goals are oriented in the management of assets and investments to improve the well-being of native people and the environment. Consequently, its activities are oriented through the acquisition of lands and investments compatible with the main mission.
Contact information:
Christian-Joseph Turcotte, Vice President
cj@turcotte.us
A New Mining Model Is Emerging - And Wall Street Is Paying Attention • B • Jul 15, 2025 9:00 AM
Sanwire Files Complaint Against Intercept Music and Trillium Partners • SNWR • Jul 15, 2025 9:00 AM
Cannabix Technologies Commences First Production of BreathLogix Alcohol Screening Devices • BLO • Jul 15, 2025 8:47 AM
Nightfood's FHVH to Pioneer AI-Driven Culinary Education in $32.5 Billion US Market • NGTF • Jul 15, 2025 8:30 AM
The Crypto Company (OTC: CRCW) Joins New OTCID Market Tier, Marking Commitment to Innovation, Transparency, and Strategic Growth • CRCW • Jul 15, 2025 8:19 AM
Avant Technologies and JV Partner, Ainnova, Complete Pivotal Meeting with U.S. FDA • AVAI • Jul 15, 2025 8:00 AM